Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis

BACKGROUND: The burden of disease due to S. pneumoniae (pneumococcus), particularly pneumonia, remains high despite the widespread use of vaccines. Drug resistant strains complicate clinical treatment and may increase costs. We estimated the annual burden and incremental costs attributable to antibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Reynolds, Courtney A, Finkelstein, Jonathan A, Ray, G Thomas, Moore, Matthew R, Huang, Susan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029811/
https://www.ncbi.nlm.nih.gov/pubmed/24851182
http://dx.doi.org/10.1186/2047-2994-3-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029811/
https://www.ncbi.nlm.nih.gov/pubmed/24851182
http://dx.doi.org/10.1186/2047-2994-3-16

Ejemplares similares